Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance |
Washington University / Nicole Brossier, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center / Colin Godwin, MD |
Young Investigator Grants |
2018 |
Washington |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
A mouse model of Wilms' Tumor
|
Massachusetts General Hospital / Nabeel Bardeesy, PhD |
Young Investigator Grants |
2008 |
Massachusetts |